1
|
Urbańczyk K, Guntschnig S, Antoniadis V, Falamic S, Kovacevic T, Kurczewska-Michalak M, Miljković B, Olearova A, Sviestina I, Szucs A, Tachkov K, Tiszai Z, Volmer D, Wiela-Hojeńska A, Fialova D, Vlcek J, Stuhec M, Hogg A, Scott M, Stewart D, Mair A, Ravera S, Lery FX, Kardas P. Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes. Front Pharmacol 2023; 14:1244151. [PMID: 37601045 PMCID: PMC10433912 DOI: 10.3389/fphar.2023.1244151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Accepted: 07/17/2023] [Indexed: 08/22/2023] Open
Abstract
Clinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across the globe gradually identified the need to focus more on ensuring the appropriate use of medicines to improve patient outcomes rather than being engaged in manufacturing and supply. Since that time numerous studies have shown the positive impact of clinical pharmacy services (CPS). The need for wider adoption of CPS worldwide becomes urgent, as the global population ages, and the prevalence of polypharmacy as well as shortage of healthcare professionals is rising. At the same time, there is great pressure to provide both high-quality and cost-effective health services. All these challenges urgently require the adoption of a new paradigm of healthcare system architecture. One of the most appropriate answers to these challenges is to increase the utilization of the potential of highly educated and skilled professionals widely available in these countries, i.e., pharmacists, who are well positioned to prevent and manage drug-related problems together with ensuring safe and effective use of medications with further care relating to medication adherence. Unfortunately, CPS are still underdeveloped and underutilized in some parts of Europe, namely, in most of the Central and Eastern European (CEE) countries. This paper reviews current situation of CPS development in CEE countries and the prospects for the future of CPS in that region.
Collapse
Affiliation(s)
- Kamila Urbańczyk
- Department of Clinical Pharmacology, Wroclaw Medical University, Wroclaw, Poland
- Regional Specialist Hospital in Wroclaw, Wroclaw, Poland
| | - Sonja Guntschnig
- Tauernklinikum Zell am See, Zell am See, Austria
- School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, Northern Ireland
| | | | - Slaven Falamic
- Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
| | - Tijana Kovacevic
- Pharmacy Department, University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina
- Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
| | | | - Branislava Miljković
- Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
| | - Anna Olearova
- Department of Clinical Pharmacology, University Hospital Bratislava—Hospital Ruzinov, Bratislava, Slovakia
| | - Inese Sviestina
- Faculty of Medicine, University of Latvia, Riga, Latvia
- Children’s Clinical University Hospital, Riga, Latvia
| | - Attila Szucs
- Pharmacy Department, National Institute of Oncology, Budapest, Hungary
| | - Konstantin Tachkov
- Department of Organization and Economy of Pharmacy, Faculty of Pharmacy, Medical University-Sofia, Sofia, Bulgaria
| | - Zita Tiszai
- Department of Hospital Pharmacy, Bajcsy-Zsilinszky Hospital, Budapest, Hungary
| | - Daisy Volmer
- Institute of Pharmacy, Faculty of Medicine, University of Tartu, Tartu, Estonia
| | - Anna Wiela-Hojeńska
- Department of Clinical Pharmacology, Wroclaw Medical University, Wroclaw, Poland
| | - Daniela Fialova
- Department of Clinical and Social Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czechia
- Department of Geriatrics and Gerontology, First Faculty of Medicine in Prague, Charles University, Prague, Czechia
| | - Jiri Vlcek
- Department of Clinical and Social Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czechia
- Clinical Pharmacy Department, Hospital Pharmacy, Teaching Hospital Hradec Kralove, Hradec Králové, Czechia
| | - Matej Stuhec
- Department of Pharmacology, Faculty of Medicine Maribor, University of Maribor, Maribor, Slovenia
- Department of Clinical Pharmacy, Ormoz Psychiatric Hospital, Ormoz, Slovenia
| | - Anita Hogg
- Medicines Optimisation Innovation Centre, Antrim Hospital, Antrim, United Kingdom
| | - Michael Scott
- Medicines Optimisation Innovation Centre, Antrim Hospital, Antrim, United Kingdom
| | - Derek Stewart
- College of Pharmacy, QU Health, Qatar University, Doha, Qatar
- European Society of Clinical Pharmacy, Leiden, Netherlands
| | - Alpana Mair
- Effective Prescribing and Therapeutics, Health and Social Care Directorate, Scottish Government, Edinburgh, United Kingdom
| | - Silvia Ravera
- European Directorate for the Quality of Medicines & Healthcare, Council of Europe, Strasbourg, France
| | - François-Xavier Lery
- European Directorate for the Quality of Medicines & Healthcare, Council of Europe, Strasbourg, France
| | - Przemysław Kardas
- Department of Family Medicine, Medical University of Lodz, Lodz, Poland
| |
Collapse
|